Interactions between P-glycoprotein and drugs used in the supportive care of acute myeloid leukemia patients

Leukemia and Lymphoma

Volumn 42, Issue 1-2, 2001, Pages 177-185

  Mollgard L ^a   Hellberg, E ^a   Smolowicz, A ^a   Paul, C ^a   Tidefelt, U ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute myeloid leukemia; Antibiotics; HL 60 cell line; P glycoprotein; Rhodamine

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTHRACYCLINE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; DAUNORUBICIN; DICLOXACILLIN; DIXYRAZINE; DOXYCYCLINE; ERYTHROMYCIN; FLUCONAZOLE; FLUORESCENT DYE; GEAVIR; GLYCOPROTEIN P; MEPREDNISONE; METOCLOPRAMIDE; ONDANSETRON; PENICILLIN G; REOCEPHALIN; RHODAMINE; RHODAMINE 123; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; ASSAY; CANCER PATIENT; CELL TRANSPORT; CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CONCENTRATION; DRUG MECHANISM; DRUG SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; LEUKEMIA CELL LINE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034915334     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109097689     Document Type: Article

References (35)

1. Clinical Relevance of transmembrane drug efflux as mechanism of multidrug resistance
2. P-glycoprotein - A mediator of multidrug resistance in tumour cells
3. Multidrug resistance in leukemia
4. Structure model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance, and bacterial transport
5. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphocytic leukemia cells at diagnosis
6. Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia
7. Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and in vivo resistance in adult acute myeloid leukemia
8. Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy
9. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein. MRP1, and LRP in acute myeloid leukemia: A Southwest Oncology Group Study
10. Overexpression of the mdr1 gene in blast cells from patients with acute myeloytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin A
11. Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods
12. Quality control of multidrug resistance assays in adult acute leukemia: Correlation between assays for P-glycoprotein expression and activity
13. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123
14. Circumvention of P-glycoprotein-mediated drug resistance in human leukemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833
15. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
16. Cyclosporins as drug resistance modifiers
17. Pharmacology of drugs that alter multidrug resistance in cancer
18. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers
19. Effect of cyclosporine A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry
20. Modulators of multidrug resistance. Pre-clinical studies
21. Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenofrafts
22. Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma
23. The MDR superfamily of genes and its biological implications
24. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stemcells
25. Reversal by cefoperazone of resistance to etoposide, doxorubicin and vinblastine in multidrug resistant sarcoma cells
26. Effect of erythromycin and tumor necrosis factor on the drug resistance of multidrug-resistant cells: Reversal of drug resistance by erythromycin
27. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells
28. Characterisation of an anthracycline resistant human promyelocytic leukemia (HL-60) cell line with an elevated MDR-1 gene expression
29. Stroma-supported immunocytometric assay (SIA): A novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs
30. Amphotericin B as a potentiation agent to cytotoxic chemotherapy
31. Multidrug resistance mediated by the multidrug resistance (MRP) gene
32. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes
33. Non-P-glycoprotein drug export mechanisms of multidrug resistance
34. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance
35. Potentiation of cisplatin and carboplatin cytotoxicity by amphotericin B in different human ovarian carcinoma and malignant peritoneal mesothelioma cells